We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Link Found Between Stem Cells and Tumors

By Biotechdaily staff writers
Posted on 13 Sep 2005
Researchers now have proof that certain kinds of cancer originates with stem cell defects. More...
A recent study demonstrates that if key molecules are not positioned in the proper locations within stem cells before they divide, the result can be deadly tumor formation.

Cells in the very early embryo are identical and undergo fast division. However, they soon begin differentiating into more specific types, eventually becoming specialized cells such as blood, neurons, or muscle. As they differentiate, they should stop dividing and usually become entrenched in specific tissues. Some tumor cells are more like stem cells because they are identical, they divide rapidly, and in the worst case--metastasis--they travel through the body and implant themselves in new tissues.

Specialized cells die by way of age or injuries, so the body keeps reserves of stem cells on hand to produce replacements. Typically, the stem cell divides into two types: one that is just like the parent, which is kept to maintain the stock, and another that differentiates. This is what occurs with neuroblasts. Cell division creates one large neuroblast and a smaller cell that can become part of a nerve. This process is controlled by events that occur before division. The parent cell becomes asymmetrical: it accumulates a set of special molecules, including Prospero and other proteins, in the region that will sprout off and become the specialized cell.

This research was performed by investigators from the European Molecular Biology Laboratory (EMBL, Heidelberg, Germany) and the Institute of Biomedical Research of the Parc Cientific de Barcelona (IRB-PCB; Spain). Their findings were published in the September 4, 2005, on-line edition of the journal Nature Genetics.

"This asymmetry provides the new cell with molecules it needs to launch new genetic programs that tell it what to become,” remarked Dr. Cayetano Gonzalez, whose team started the project at EMBL and has continued to study the process as they moved to the IRB-PCB. "The current study investigates what happens when the process of localizing these molecules is disturbed.”

Whether Prospero and its cohorts get to the proper place depends on the activity of specific genes in the stem cell. Emmanuel Caussinus, an EMBL Ph.D. student from Dr. González's group, created neuroblasts in which these genes were disrupted. "We no longer had normal neuroblasts and daughter cells capable of becoming part of a nerve,” Mr. Caussinus noted. "Instead, we had a tumor.”

When these modified cells were transplanted into flies, the results were quick and dramatic. The tissue containing the modified cells grew to 100 times its initial size, cells invaded other tissues, and death followed. The growing tumor became "immortal,” according to Mr. Caussinus. Cells could be re-transplanted into new hosts for years, generation after generation, with similar effects.

This study confirms that certain genes in stem cells--those which regulate the destinies of daughter cells--are vital. If such genes are disrupted, the new cells may no longer be able to control their reproduction, and this could lead to cancer. "It puts the focus on the events that create asymmetrical collections of molecules inside stem cells,” said Dr. González. "This suggests new lines of investigation into the relationship between stem cells and tumors in other model organisms and humans.”


Related Links:
European Molecular Biology Laboratory
Parc Cientific de Barcelona

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.